Effectiveness of Text Messaging Intervention to Improve Dietary Behaviors Among Patients with Type 2 Diabetes Mellitus in Low Resource Area of Sabah (DTEXT-SBH)
Launched by UNIVERSITI MALAYSIA SABAH · Sep 5, 2024
Trial Information
Current as of July 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The DTEXT-SBH clinical trial is looking to see if sending three text messages each week for six months can help people with Type 2 Diabetes Mellitus (T2DM) in areas where they don't have easy access to dietitians stick to a healthier diet. The researchers want to find out if these messages can improve how well patients follow dietary advice and if it can help lower their blood sugar levels, measured by a test called HbA1c. Participants will be divided into two groups: one will receive the text messages, while both groups will receive standard nutrition advice at the beginning and during follow-up visits at three and six months.
To be eligible for this trial, participants need to have Type 2 diabetes, own a mobile phone, be able to read and speak Bahasa Malaysia, and have an HbA1c level above 7.0%. They should not have seen a dietitian in the last six months. People with Type 1 diabetes, serious complications from diabetes, or certain other health issues will not be included. If you join the study, you can expect to receive helpful messages aimed at supporting your dietary choices while also keeping regular appointments for nutritional guidance. This trial is not yet recruiting, but it aims to provide valuable insights for managing diabetes in resource-limited areas.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • have type 2 diabetes.
- • own a mobile phone.
- • able to use WhatsApp.
- • able to read and speak Bahasa Malaysia.
- • have an HbA1c level above 7.0%.
- • have not seen a dietitian in the previous 6 months.
- Exclusion Criteria:
- • individuals with type 1 diabetes mellitus and gestational diabetes mellitus.
- • patients with cognitive impairment affecting memory, attention, language, and problem-solving skills.
- • those with advanced diabetic complications, such as kidney failure and neuropathy.
- • individuals lacking regular access to a mobile phone or with poor network connectivity.
- • pregnant individuals or those planning to get pregnant in the next 6 months, as well as those currently nursing.
- • individuals with major illnesses like cancer or advanced heart disease.
- • those planning major surgery or gastric bypass in the next 6 months.
- • institutionalized individuals, such as those in nursing homes, old folks\' homes, or imprisoned.
About Universiti Malaysia Sabah
Universiti Malaysia Sabah (UMS) is a leading Malaysian institution dedicated to advancing research and education in various fields, including health sciences. As a clinical trial sponsor, UMS is committed to enhancing public health through innovative research initiatives that adhere to ethical standards and regulatory guidelines. The university fosters collaboration among multidisciplinary teams and leverages its state-of-the-art facilities to conduct rigorous clinical trials aimed at generating valuable data to inform medical practices and improve patient outcomes. UMS's emphasis on quality research and community engagement positions it as a key player in the advancement of health-related knowledge and solutions in Malaysia and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kota Kinabalu, Sabah, Malaysia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported